Article

A pan-cancer analysis of the oncogenic role of ribonucleotide reductase subunit M2 in human tumors

2022-10-31

Abstract excerpt

Although there is evidence that ribonucleotide reductase subunit M2 (RRM2) is associated with many cancers, no pan-cancer analysis is available. This study aims to explore the potential oncogenic role of RRM2 in pan-cancer based on the datasets of TCGA (The cancer genome atlas). RRM2 was highly expressed in most cancers and obvious correlation existed between RRM2 expression and prognosis of tumor patients. RRM2 e...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: aa0cadf3-1d04-50c1-8766-3cb01c980404
DOI: 10.21203/rs.3.rs-2215057/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

A pan-cancer analysis of the oncogenic role of ribonucleotide reductase subunit M2 in human tumorsDOI 10.21203/rs.3.rs-2215057/v1Read

Comprehensive Landscape of RRM2 with Immune Infiltration in Pan-CancerSemantic proximity Read

Ribonucleotide reductase M2 (RRM2): Regulation, function and targeting strategy in human cancerSemantic proximity Read

Pan-cancer analysis reveals potential of RRM2 as a prognostic and immunological biomarker in human cancerSemantic proximity Read

Independent prognostic implications of RRM2 in lung adenocarcinomaSemantic proximity Read

RRM2 silencing suppresses malignant phenotype and enhances radiosensitivity via activating cGAS/STING signaling pathway in lung adenocarcinomaSemantic proximity Read

Over-expression of RRM2 Predicts Poor Prognosis in Hepatocellular Carcinoma: A Bioinformatics Analysis Based on TCGA DataSemantic proximity Read

Pan-Cancer Analysis of Molecular Characteristics and Oncogenic Role of PRMT5 in Human CancersSemantic proximity Read

RRM2 is a potential prognostic biomarker with functional significance in gliomaSemantic proximity Read

Downregulation of ribonucleotide reductase subunits M2 induces apoptosis and G1 arrest of cervical cancer cellsSemantic proximity Read

Ribonucleotide reductase small subunit M2 serves as a prognostic biomarker and predicts poor survival of colorectal cancersSemantic proximity Read

Ribonucleotide reductase small subunit M2 is a master driver of aggressive prostate cancerSemantic proximity Read

Repositioning of a cyclin-dependent kinase inhibitor GW8510 as a ribonucleotide reductase M2 inhibitor to treat human colorectal cancerSemantic proximity Read